缺血性心肌病的血运重建治疗  

Revascularization in Ischemic Cardiomyopathy

作　　者：姜琳[1] 袁晋青[1] 

机构地区：[1]北京协和医学院中国医学科学院国家心血管病中心阜外医院心血管内科,北京100037

出　　处：《心血管病学进展》2015年第6期677-681,共5页Advances in Cardiovascular Diseases

基　　金：国家"十二五"科技支撑计划(2011BAI11B07)

摘　　要：缺血性心肌病是导致心力衰竭常见的原因。通过早期血运重建挽救冬眠心肌,可能在阻止和逆转心室重塑方面起到决定性作用。然而,由于缺血性心肌病患者的心功能严重受损,且冠状动脉病变往往较复杂,因此行血运重建的风险较高。目前关于血运重建能否改善心力衰竭患者的预后仍存争议。现阐述缺血性心肌病患者血运重建治疗的研究进展。Ischemic cardiomyopathy is the most common cause of heart failure. Early revascularization of viable myocardium may play a critical role in preventing and reversing ventricular remodeling. However,there is an increased risk of morbidity related to the revascularization procedure in patients with ischemic cardiomyopathy due to severely impaired cardiac function and complex coronary lesions. The role of coronary revascularization in improving heart failure associated morbidity and mortality remains controversial. In this review,the research progression of revascularization in ischemic cardiomyopathy is discussed.

关 键 词：缺血性心肌病 心力衰竭 血运重建 

分 类 号：R542.2[医药卫生—心血管疾病]